The comparison is completely unrelated but the thesis holds true. Beyond all comparisons you seriously need to consider whether spending $20.7m a year for $3m in revenue is justified. For the US to be NPAT accretive NEA needs US revenues to be greater than $20.7m. Currently no one can see that far ahead when/if that is possible
